| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Department of Molecular Biology, 2 Microarray Service Laboratory, The Core Research Facility, and 3 Lautenberg Center for General and Tumor Immunology, Hebrew University Medical School, Jerusalem, Israel
Requests for reprints: Itamar Simon, Department of Molecular Biology, Hebrew University, Jerusalem 91120, Israel. Phone: 972-2-6758544; Fax: 972-2-6758992; E-mail: itamarsi{at}ekmd.huji.ac.il.
Key Words: apoptosis cell cycle arrest ChIP on chip microarray p53
The p53 tumor suppressor protein is a transcription factor that plays a key role in the cellular response to stress and cancer prevention. Upon activation, p53 regulates a large variety of genes causing cell cycle arrest, apoptosis, or senescence. We have developed a p53-focused array, which allows us to investigate, simultaneously, p53 interactions with most of its known target sequences using the chromatin immunoprecipitation (ChIP)-on-chip methodology. Applying this technique to multiple cell types under various growth conditions revealed a profound difference in p53 activity between primary cells and established cell lines. We found that, in peripheral blood mononuclear cells, p53 exists in a form that binds only a small subset of its target regions. Upon exposure to genotoxic stress, the extent of targets bound by p53 significantly increased. By contrast, in established cell lines, p53 binds to essentially all of its targets irrespective of stress and cellular fate (apoptosis or arrest). Analysis of gene expression in these established lines revealed little correlation between DNA binding and the induction of gene expression. Our results suggest that nonactivated p53 has limited binding activity, whereas upon activation it binds to essentially all its targets. Additional triggers are most likely required to activate the transcriptional program of p53. [Cancer Res 2008;68(23):9671–7]
This article has been cited by other articles:
![]() |
J.-F. Millau, N. Bastien, E. F. Bouchard, and R. Drouin p53 Pre- and Post-Binding Event Theories Revisited: Stresses Reveal Specific and Dynamic p53-Binding Patterns on the p21 Gene Promoter Cancer Res., November 1, 2009; 69(21): 8463 - 8471. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Llanos, A. Cuadrado, and M. Serrano MSK2 Inhibits p53 Activity in the Absence of Stress Sci. Signal., September 22, 2009; 2(89): ra57 - ra57. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |